Logo.png
Vyant Bio Commences a Cash Preservation Plan Including a Reduction in Force
February 03, 2023 06:00 ET | Vyant Bio, Inc.
Continuing to Explore Strategic Alternatives CHERRY HILL, N.J., Feb. 03, 2023 (GLOBE NEWSWIRE) -- Vyant Bio, Inc. (“Vyant Bio” or “Company”) (Nasdaq: VYNT) is an innovative biotechnology company...
Logo.png
Vyant Bio Announces One-for-Five Reverse Stock Split
November 01, 2022 08:00 ET | Vyant Bio, Inc.
CHERRY HILL, N.J., Nov. 01, 2022 (GLOBE NEWSWIRE) -- Vyant Bio, Inc. (“Vyant Bio” or “Company”) (Nasdaq: VYNT) is an innovative biotechnology company reinventing drug discovery for complex...
Logo.png
Vyant Bio to Deliver a Live Presentation at the Skyline Signature Series™ on Thursday, September 8, 2022
September 01, 2022 08:00 ET | Vyant Bio, Inc.
-Invites individual and institutional investors, as well as advisors and analysts, to attend this real-time, interactive presentation at the Skyline Signature Series™ CHERRY HILL, N.J., Sept. 01,...